Trial results show promise for chemo-free future treatment
95% of those treated in the study were found to have a complete remission rate.
Read More
Tag: Leicester
Leicester first UK city chosen for global diabetes initiative
Leicester is the first UK city to be chosen for the Novo Nordisk-led global initiative Cities Changing Diabetes, which aims to tackle the dramatic rise of type II diabetes in urban areas.
Read More
- Pierre Fabre Laboratories secures CHMP backing for first‑line BRAFTOVI regimen
- Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
